World Hepatitis Day 2020
ECDC coordinates the enhanced surveillance for hepatitis A, B and C to help countries define epidemiological trends or transmission patterns among newly diagnosed cases.
World Hepatitis Day on 28 July provides an opportunity each year to increase the awareness and understanding of viral hepatitis.
Viral hepatitis is an inflammation of the liver caused by a virus. The most common hepatitis viruses in Europe are types A, B, C and E (commonly referred to as HAV, HBV, HCV and HEV). Together, HBV and HCV are the most common cause of liver cirrhosis and cancer.
European surveillance data show on-going transmission of hepatitis B and high annual levels of hepatitis C diagnoses.
That is why targeted testing to reach those most at-risk of infection is an essential element of any strategy to eliminate viral hepatitis across the countries in the European Union and European Economic Area (EU/EEA) as outlined in the Sustainable Development Goals for 2030.
However, according to recent ECDC findings, only a few countries across the EU/EEA have met the 2020 target of the European Action Plan in diagnosing 50% of people with chronic hepatitis B or C.
Monitoring the progress towards hepatitis B and C elimination
Surveillance data and tools
Public health guidance
Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA
5 Dec 2018 - The ECDC guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV supports countries in the global effort to combat viral hepatitis and eliminate HIV as public health threats by 2030. At present, reaching and testing those at risk of infection with HIV, HBV or HCV is still a public health challenge across Europe. This Guidance in brief is based on the comprehensive guidance document which provides the evidence base for this guidance
Public health guidance on HIV, hepatitis B and C testing in the EU/EEA
23 Nov 2018 - This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
Guidance in brief: Prevention and control of blood-borne viruses in prison settings
23 Jul 2018 - This guidance is intended for policymakers responsible for the planning and delivery of healthcare services in the national or sub-national custodial system and all professionals responsible for the health and well-being of people in prison, including community-based service providers and those facilitating continuity of care in the community.